desipramine has been researched along with Amyotrophic Lateral Sclerosis in 3 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Salado, IG | 1 |
Redondo, M | 1 |
Bello, ML | 1 |
Perez, C | 1 |
Liachko, NF | 1 |
Kraemer, BC | 1 |
Miguel, L | 1 |
Lecourtois, M | 1 |
Gil, C | 2 |
Martinez, A | 2 |
Perez, DI | 1 |
Nozal, V | 1 |
Martínez-González, L | 1 |
Gomez-Almeria, M | 1 |
Gonzalo-Consuegra, C | 1 |
Santana, P | 1 |
Chaikuad, A | 1 |
Pérez-Cuevas, E | 1 |
Knapp, S | 1 |
Lietha, D | 1 |
Ramírez, D | 1 |
Petralla, S | 1 |
Monti, B | 1 |
Martín-Requero, A | 1 |
Palomo, V | 1 |
de Lago, E | 1 |
Sawada, J | 1 |
Yamashita, T | 1 |
Aizawa, H | 1 |
Aburakawa, Y | 1 |
Hasebe, N | 1 |
Kwak, S | 1 |
3 other studies available for desipramine and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Benzothiazoles; Blood-Brain B | 2014 |
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy.
Topics: Amyotrophic Lateral Sclerosis; Animals; Brain; Case-Control Studies; DNA-Binding Proteins; Humans; I | 2022 |
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; | 2009 |